SCHEMBL23728948

SCHEMBL23728948

COC(=O)CCNC(=O)c1nc(NCCCN)cn1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
KDM5B Q9UGL1 1/20 0.36
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HRH3 Q9Y5N1 2/20 0.32
HRH4 Q9H3N8 1/20 0.32
MAPT P10636 1/20 0.32
CA12 O43570 1/20 0.31
CA3 P07451 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
CA13 Q8N1Q1 1/20 0.31
CA14 Q9ULX7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23728962 0.99 CA1 (0.38) CA1CA2KDM5BHDAC1HDAC2
SCHEMBL23744918 0.84 HDAC1 (0.42) KDM5BHDAC1HDAC2HDAC8SMN1; SMN2
Hydrochloric Acid SCHEMBL28984120 0.83 HDAC1 (0.41) KDM5BHDAC1HDAC2HDAC8SMN1; SMN2
SCHEMBL13928878 0.81 HDAC1 (0.43) HDAC1HDAC2HDAC8HASPIN
SCHEMBL23728778 0.80 HRAS (0.39) CA1CA2HDAC1HDAC2HDAC8
SCHEMBL30125599 0.79 HDAC1 (0.38) KDM5BHDAC1HDAC2HDAC8SMN1; SMN2
SCHEMBL22824758 0.79 KDM5B (0.38) CA1CA2KDM5BSMN1; SMN2ALDH1A1
SCHEMBL26725602 0.77 KDM5B (0.41) KDM5BSMN1; SMN2ALDH1A1MAPTCA12
SCHEMBL13928636 0.77 HDAC1 (0.34) HDAC1HDAC2HDAC8ALDH1A1HRH3
SCHEMBL22824757 0.76 GSK3B (0.36) KDM5BHDAC1HDAC2HDAC8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4384506-A1 PROCESS FOR POLYAMIDE SYNTHESIS Design Therapeutics, Inc. (US) 2024-06-19 EP disclosed
WO-2023014793-A1 PROCESS FOR POLYAMIDE SYNTHESIS Design Therapeutics, Inc. (US) 2023-02-09 WO disclosed
EP-4100404-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2022-12-14 EP disclosed
WO-2021158707-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2021-08-12 WO disclosed